https://openalex.org/T11064
This cluster of papers focuses on the use of antiplatelet therapy, including aspirin, clopidogrel, and ticagrelor, in the prevention of cardiovascular events, especially in the context of percutaneous coronary intervention. It also explores the impact of genetic polymorphisms, platelet reactivity, and bleeding risk on the efficacy and safety of antiplatelet drugs.
@prefix oasubfields: <https://openalex.org/subfields/> .
@prefix openalex: <https://lambdamusic.github.io/openalex-hacks/ontology/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
<https://openalex.org/T11064> a skos:Concept ;
rdfs:label "Antiplatelet Therapy in Cardiovascular Disease"@en ;
rdfs:isDefinedBy openalex: ;
owl:sameAs <https://en.wikipedia.org/wiki/Antiplatelet_drug>,
<https://openalex.org/T11064> ;
skos:broader oasubfields:2705 ;
skos:definition "This cluster of papers focuses on the use of antiplatelet therapy, including aspirin, clopidogrel, and ticagrelor, in the prevention of cardiovascular events, especially in the context of percutaneous coronary intervention. It also explores the impact of genetic polymorphisms, platelet reactivity, and bleeding risk on the efficacy and safety of antiplatelet drugs."@en ;
skos:inScheme openalex: ;
skos:prefLabel "Antiplatelet Therapy in Cardiovascular Disease"@en ;
openalex:cited_by_count 889548 ;
openalex:works_count 54742 .